Recent research has shed light on various pathways through which cancer cells acquire resistance to Tx, including alterations in tubulin dynamics, modulation of nuclear factor κB (NF-κB), and overexpression of ATP-binding cassette (ABC) transporters (Długosz-Pokorska et al. 2023; Němcová-Fürstová et al. 2016; Murray et al. 2012). This evidence concerns the gene NFKB1 and cancer.